Alar Pharmaceuticals Inc. 6785.TWO Stock
Alar Pharmaceuticals Inc. Price Chart
Alar Pharmaceuticals Inc. 6785.TWO Financial and Trading Overview
| Alar Pharmaceuticals Inc. stock price | 320.5 TWD |
| Previous Close | 162.5 TWD |
| Open | 159.5 TWD |
| Bid | 161.5 TWD x N/A |
| Ask | 162.5 TWD x N/A |
| Day's Range | 159 - 164 TWD |
| 52 Week Range | 44.05 - 221 TWD |
| Volume | 109.37K TWD |
| Avg. Volume | 76.44K TWD |
| Market Cap | 9.26B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 6.7 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6785.TWO Valuation Measures
| Enterprise Value | 10.15B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 18.003546 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Alar Pharmaceuticals Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 234.78% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 221 TWD |
| 52 Week Low | 44.05 TWD |
| 50-Day Moving Average | 175.15 TWD |
| 200-Day Moving Average | 132.38 TWD |
6785.TWO Share Statistics
| Avg. Volume (3 month) | 76.44K TWD |
| Avg. Daily Volume (10-Days) | 69.87K TWD |
| Shares Outstanding | 57M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.01 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 800K TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.46 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 9.026 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Alar Pharmaceuticals Inc.
| Country | Taiwan |
| State | N/A |
| City | Taichung |
| Address | No. 19, Keyuan Road |
| ZIP | 407 |
| Phone | 886 4 2463 7115 |
| Website | https://www.alarpharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 21 |
Alar Pharmaceuticals Inc. operates as a drug development company. It focuses on developing long-acting release drug products for CNS disorders and chronic diseases, which primarily include opioid use disorder, chronic pain, and major depressive disorder. The company is developing ALA-1000, which is in Phase II clinical trials for the treatment of opioid addiction; and ALA-1300 and ALA-2000, which is in pre-clinical stage for opioid use disorder; and ALA-3000, which is in pre-clinical stage for treating treatment-resistant depression. The company was founded in 2016 and is based in Taichung, Taiwan.
Q&A For Alar Pharmaceuticals Inc. Stock
What is a current 6785.TWO stock price?
Alar Pharmaceuticals Inc. 6785.TWO stock price today per share is 320.5 TWD.
How to purchase Alar Pharmaceuticals Inc. stock?
You can buy 6785.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alar Pharmaceuticals Inc.?
The stock symbol or ticker of Alar Pharmaceuticals Inc. is 6785.TWO.
Which industry does the Alar Pharmaceuticals Inc. company belong to?
The Alar Pharmaceuticals Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Alar Pharmaceuticals Inc. have in circulation?
The max supply of Alar Pharmaceuticals Inc. shares is 57M.
What is Alar Pharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?
Alar Pharmaceuticals Inc. PE Ratio is 47.83582300 now.
What was Alar Pharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?
Alar Pharmaceuticals Inc. EPS is 6.7 TWD over the trailing 12 months.
Which sector does the Alar Pharmaceuticals Inc. company belong to?
The Alar Pharmaceuticals Inc. sector is Healthcare.